[HTML][HTML] Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic …

SMH Chan, S Selemidis, S Bozinovski… - Pharmacology & …, 2019 - Elsevier
Chronic obstructive pulmonary disease (COPD) is a major incurable global health burden
and is currently the 4th largest cause of death in the world. Importantly, much of the disease …

Chronic obstructive pulmonary disease and diabetes mellitus: a systematic review of the literature

S Gläser, S Krüger, M Merkel, P Bramlage, FJF Herth - Respiration, 2015 - karger.com
The objective of this systematic review was to discuss our current understanding of the
complex relationship between chronic obstructive pulmonary disease (COPD) and type-2 …

Inhaled corticosteroids and the risks of diabetes onset and progression

S Suissa, A Kezouh, P Ernst - The American journal of medicine, 2010 - Elsevier
BACKGROUND:: Systemic corticosteroids are known to increase diabetes risk, but the
effects of high-dose inhaled corticosteroids are unknown. We assessed whether the use and …

Inhaled corticosteroids in COPD: the clinical evidence

P Ernst, N Saad, S Suissa - European Respiratory Journal, 2015 - Eur Respiratory Soc
In this article, we focus on the scientific evidence from randomised trials supporting
treatment with inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease …

Mechanisms linking COPD to type 1 and 2 diabetes mellitus: is there a relationship between diabetes and COPD?

SS Park, JL Perez Perez, B Perez Gandara… - Medicina, 2022 - mdpi.com
Chronic obstructive pulmonary disease (COPD) patients frequently suffer from multiple
comorbidities, resulting in poor outcomes for these patients. Diabetes is observed at a …

Хроническая обструктивная болезнь легких и кардиоваскулярная патология

НА Кароли, АП Ребров - Клиницист, 2007 - cyberleninka.ru
Полиморбидность является одной из особенностей современной клиники внутренних
болезней, а ишемическая болезнь сердца (ИБС), артериальная гипертензия и …

Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): a nested case–control analysis

JC Wilson, K Sarsour, N Collinson, K Tuckwell… - Seminars in arthritis and …, 2017 - Elsevier
Objective Giant cell arteritis (GCA) is an inflammatory vasculitis preferentially affecting large
and medium-sized arteries. High-dose oral glucocorticoids (GCs) are the mainstay of GCA …

[HTML][HTML] Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids

PM O'Byrne, S Rennard, H Gerstein, F Radner… - Respiratory …, 2012 - Elsevier
BACKGROUND: A recent case-controlled study reported an increased risk of diabetes
mellitus in patients treated with inhaled corticosteroids for asthma or COPD, versus age …

Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study

DB Price, J Voorham, G Brusselle, A Clemens… - NPJ primary care …, 2019 - nature.com
Some studies suggest an association between onset and/or poor control of type 2 diabetes
mellitus and inhaled corticosteroid (ICS) therapy for chronic obstructive pulmonary disease …

Targeting mechanisms linking COPD to type 2 diabetes mellitus

M Cazzola, P Rogliani, L Calzetta, D Lauro… - Trends in …, 2017 - cell.com
Chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus (T2DM) often
coexist. The mechanistic links between these two diseases are complex, multifactorial, and …